During developmental angiogenesis blood vessels grow and remodel to ultimately build a hierarchical vascular network. Whether and how cell death signaling molecules contribute to blood vessel formation is still not well understood. Caspase-8 (Casp-8), a key protease in the extrinsic cell death-signaling pathway, regulates both cell death via apoptosis and necroptosis. Here we show that expression of Casp-8 in endothelial cells (ECs) is required for proper postnatal angiogenesis. EC specific Casp-8 knockout pups (Casp-8 ECko ) have reduced retinal angiogenesis, as the loss of Casp-8 reduced EC proliferation, sprouting and migration independent of its cell death function. Instead, the loss of Casp-8 caused hyperactivation of p38 mitogen-activated protein kinase (MAPK) downstream of receptorinteracting serine/threonine-protein kinase 3 (RIPK3) and destabilization of VE-cadherin at EC
regulate cell death-independent processes such as cell migration (14, 15) , or proliferation (16) and to act as DNA-damage sensor induced by cell proliferation (17) .
Deletion of Casp-8 in mice is embryonically lethal. Interestingly, Casp-8 knockout mouse embryos die at mid-gestation presenting a circulatory failure phenotype and damaged blood vessel capillaries (18) (19) (20) . Endothelial cell (EC) specific knockout of Casp-8 during embryonic development mimics the severity of the full knockout (21) , suggesting that Casp-8 in ECs is required for the formation of a proper vascular system. However, whether Casp-8 is also required at later timepoints during vessel development, and whether it plays a cell-death dependent or independent function, remains unknown.
In this regard, cell death-dependent and -independent functions of RIPK3 have been described in pathological angiogenesis. In a mouse model of melanoma metastasis, it has been shown that RIPK3 is involved in tumor-induced EC necroptosis but also in vessel permeability via activation of p38 (22, 23) . Whether RIPK3 is not only contributing to pathological vessel formation and function, but also to vessel stability in physiological conditions of angiogenesis, is so far unknown.
Here, using a conditional inducible EC specific Casp-8 knockout mouse line, we show that the loss of Casp-8 results in reduced postnatal angiogenesis. Most strikingly, we demonstrate that this phenotype is independent of necroptosis, as the loss of Casp-8 on a MLKL-null background still results in vascular defects. Instead, Casp-8 regulates EC proliferation, sprouting and migration, as well as the stability of adherens and tight junctions. Mechanistically, we show that loss of Casp-8 leads to the constitutive phosphorylation of p38 mitogen-activated protein kinase (MAPK) via RIPK3 and to defects in VEcadherin subcellular localization. Applying the oxygen induced retinopathy model (OIR), a model that resembles the pathology of ROP, we show that the loss of Casp-8 in ECs is beneficial, as pathological neovascularization in Casp-8 knockout mice is reduced. 5 
RESULTS

Postnatal deletion of Casp-8 in ECs results in impaired angiogenesis in the retina
To explore the function of Casp-8 during developmental angiogenesis in vivo, we generated inducible EC specific Casp-8 knockout mice. To do so, we crossed the tamoxifen inducible Cdh5-(PAC)-CreERT2 mouse line (24) , where Cre-recombinase is expressed under control of the EC specific Cdh-5 promoter, with Casp-8 fl/fl mice. Consistent with previously published data (21) , therefore validating our generated mouse line, knockout of Casp-8 in the endothelium during embryonic development resulted in yolk sac and embryo vascular defects as well as in increased embryonic lethality and defects in the yolk sac vasculature (Suppl. Fig. 1A,B ).
To analyze the effect of loss of Casp-8 in ECs during postnatal vascular development, we induced Cre recombination in newborn pups as previously described (25) (Fig. 1A) and checked the recombination efficiency in isolated lung ECs (Suppl. Fig. 1C,D) . Tamoxifen treatment resulted in 70% reduction of Casp-8 mRNA levels in lung ECs from Casp-8 ECko pups at postnatal (P) day 6 (Suppl. Fig. 1D ). In contrast to the lethal effects of loss of Casp-8 in the embryonic vasculature, postnatal knockout of Casp-8 was not lethal during the time the mice were observed (until P15) and pups were indistinguishable from Casp-8 WT littermates (Suppl. Fig. 1E -G). As Casp-8 is expressed in ECs of developing blood vessels in the retina (Suppl. Fig. 1H ), and as this is a well-established model to postnatally study developmental angiogenesis (26) , we used the growing retina for our purposes. Analysis of the vasculature (by staining with the endothelial marker IsoB4) in P6 retinas showed that the total area covered by blood vessels and the vascular outgrowth were reduced in Casp-8 ECko retinas compared to Casp-8 WT littermates (Fig. 1B-D) . The number of vessel branches was also decreased (Fig. 1E,F) , indicating a reduced complexity of the vascular network in Casp-8 ECko pups. In addition, we counted less sprouts at the angiogenic front in Casp-8 ECko pups ( Fig.1 G,H) .
Altogether, this data show that loss of Casp-8 in the endothelium results in vascular defects during developmental angiogenesis. 6 
Necroptosis does not contribute to the vascular defects in Casp-8 ECko pups
During postnatal angiogenesis in the retina, the vascular network develops to its final mature stage via a combination of different cellular processes such as EC proliferation, migration, vessel maturation and vessel remodeling. As Casp-8 regulates cell death and survival, and as this contributes to vessel remodeling and regression (5, 8, 9) , we checked whether knockout of Casp-8 would result in EC death due to activation of the necroptotic pathway. In vivo, an indirect way to assess cell death is the quantification of regressing vessel branches, which leave a Collagen type IV (ColIV + ) empty sleeves behind (27) . Therefore, we analyzed vessel regression by quantifying the number of CollV + IsoB4sleeves and found no differences between genotypes ( Fig. 2A,B ). In line with these results, pericyte coverage analyzed by co-staining of the pericyte marker Desmin and IsoB4 revealed no differences between Casp-8 ECko and Casp-8 WT retinas, indicating that vessel maturation and stabilization were also not affected (Fig. 2C, D) . Interestingly, we noticed a small but significant decrease in the number of cleaved Caspase-3 + (cCasp3 + ) and TUNEL + ECs in Casp-8 ECko pups ( Fig. 2E-H ), suggesting that Casp-8 mediated apoptosis via the extrinsic cell death signaling pathway may have a small but significant contribution to the physiological remodeling process, however without affecting overall vessel regression. To further explore this hypothesis, we first analyzed the ability of ECs to die by necroptosis in vitro. For this purpose, we counted the number of propidium iodide positive cells (PI + , which detects apoptotic and necroptotic cells (28) ) in wildtype (Casp-8 WT ) and Casp-8 knockdown (Casp-8 KD ) HUVECs using a lentivirus-mediated shRNA knockdown system (29) (Suppl. Fig. 2A ). Both Casp-8 WT and Casp-8 KD HUVECs showed a slight, though not significant, increase in the number of PI + cells upon TRAIL or TNF stimulation (Suppl. Fig. 2B ). As a positive control to demonstrate that HUVECs were not just resistant to cell death, we knocked down c-FLIP (c-FLIP KD ), the intrinsic inhibitor of Casp-8. c-FLIP KD ECs presented a significant increase in cell death upon TNF or TRAIL stimulation (Suppl. Fig. 2B ). As vessel development in the retina is regulated by hypoxia (30) , and hypoxia can be a modulator of cell death (31) , we also performed the same experiments under hypoxic conditions, which produced the same results (Suppl. Fig. 2C ). 7 Finally, to determine whether necroptosis could contribute to the observed phenotype in vivo, we genetically deleted MLKL (the ultimate effector of necroptosis (13) ) in the Casp-8 ECko mice by crossing Cdh5-(PAC)-CreERT2 x Casp-8 fl/fl mice with a MLKL ko mouse line. The vessel area and the number of vessel branches at P6 were not affected in heterozygous or homozygous MLKL ko pups compared to wildtype littermates (Suppl. Fig. 3A-D) , indicating that MLKL alone did not contribute to angiogenesis.
However, the vessel area and the number of vessel branches as well as the sprouts at the angiogenic front were still reduced in Casp-8 ECko /MLKL ko pups (compared to Casp-8 WT /MLKL ko pups) ( Fig. 2I-M 
showing that blocking necroptosis in Casp-8 ECko pups did not rescue the vascular defects.
Our data indicate that the loss of Casp-8 in ECs during postnatal development does not induce cell death via necroptosis. Even though we found a mild decrease in the number of cCasp-3 + and TUNEL + ECs at P6 in Casp-8 ECko pups, this did overall not affect the percentage of vessel regression, indicating that extrinsic cell death is not an active driver of vessel pruning during postnatal vascular development.
Our data further suggest that Casp-8 regulates developmental angiogenesis in a cell death-independent way.
Casp-8 regulates VEGF-induced EC sprouting, proliferation, and migration
It has been shown that Casp-8 has diverse cell death-independent functions, for example in the regulation of cell migration (14, 32) . Thus, to further characterize the EC phenotype and to understand which processes are impaired upon loss of Casp-8, we analyzed the response of Casp-8 KD ECs upon VEGF stimulation. To do so, we analyzed EC sprouting in vitro using the bead sprouting assay (33) .
While knockdown of Casp-8 (using a specific siRNA, Suppl. Fig. 4A ) had no effect on unstimulated conditions, Casp-8 KD ECs failed to respond to VEGF stimulation (Fig. 3A,B ). Additionally, we tested the response of Casp-8 KD ECs to VEGF stimulation using the tube formation assay. Consistently, the ability of Casp-8 KD ECs to form capillary-like tube structures upon VEGF stimulation was also significantly attenuated (Suppl. Fig. 4B ,C).
We next analyzed whether Casp-8 activity was required for the proper response of ECs to VEGF stimulation. Using a luminescent Glo-assay, we first confirmed that ECs have a basal Casp-8 activity, 8 which could be blocked with the Casp-8 inhibitor Z-IETD-FMK (ZIETD, Suppl. Fig. 4D ). As a positive control for our assay, we treated ECs with a combination of cycloheximide (CHX) and TNF to induce apoptosis, which strongly increased Casp-8 activity, as expected (Suppl. Fig. 4D ). Functionally, blocking Casp-8 activity in ECs resulted in the same defects as the knockdown of Casp-8, as ZIETD treated ECs did not form sprouts upon VEGF stimulation (Suppl. Fig. 4E ,F), indicating that Casp-8 activity was required for proper angiogenesis.
To assess if changes in EC proliferation could contribute to the reduced vascular area in Casp-8 ECko retinas, we performed proliferation experiments. ShRNA-mediated Casp-8 knockdown in HUVECs resulted in reduced proliferation upon stimulation with VEGF or FGF as determined by BrdU incorporation (Suppl. Fig. 4G ). Also, siRNA transfected Casp-8 KD HUVECs had a reduced response to VEGF stimulation in the WST-1 cell proliferation and viability assay (Suppl. Fig. 4H ). In vivo, the total number of ECs as determined by counting ERG+ nuclei per retina area (ERG is an EC specific transcription factor (34)) was reduced ( Fig. 3C ,D,F). EdU labeling of proliferating cells in P6 retinas showed significantly less EdU + /ERG + cells per vessel area in Casp-8 ECko pups compared to Casp-8 WT littermates ( Fig. 3C ,E,G), indicating that reduced EC proliferation could account for the reduced vessel area.
EC migration is also required for proper expansion of the vascular network. We therefore checked whether knockdown of Casp-8 in ECs could also affect this process. In a classical scratch wound assay, VEGF stimulation of Casp-8 WT ECs led to almost 80% closure of the wound, whereas knockdown of Casp-8 reduced VEGF-induced wound closure (Suppl. Fig. 4I ,J). To determine if Casp-8 affected migration independent of its effects on proliferation, we performed live imaging experiments and tracked the movement of non-dividing single Casp-8 KD ECs. Indeed, the total migration distance of ECs after 12h of VEGF stimulation was reduced when Casp-8 was knocked down (Fig. 3H ,I).
Altogether, these results show that Casp-8 regulates EC proliferation and migration, which contributes to VEGF-induced sprouting. 9 
Loss of Casp-8 affects the organization of adherens and tight junctions in ECs
Apart of being important for vascular homeostasis and vessel stability, dynamic turnover of vascular endothelial cadherin (VE-cadherin) is crucial for proper vessel sprouting and elongation during angiogenesis (35) (36) (37) (38) (39) .
As both sprouting and migration were impaired in Casp-8 ECko mice, and as Casp-8 has been shown to regulate the stability of cell junctions in the epidermis (40) , we analyzed the distribution of VE-cadherin in vivo in the sprouting front and in the plexus of the growing vasculature of P6 retinas. By using an established image software analysis and classification key (35, 41) , we distinguished between remodeling ('active') and stable ('inhibited') VE-cadherin patches. As expected, Casp-8 WT retinas presented a highly active VE-cadherin pattern in the sprouting front that was only slightly affected in Casp-8 ECko pups (Suppl Fig. 5A -C). More strikingly, Casp-8 ECko retinas had a destabilized, more discontinuous ('active') VE-cadherin staining in the back (plexus) of the retina, where Casp-8 WT retinas showed continuous ('inhibited') patches of VE-cadherin ( Fig. 4A-C) . Analysis of the distribution of Claudin-5 in the plexus, one of the main transmembrane proteins found in tight junctions, showed the same discontinuous pattern in the back of Casp-8 ECko retinas (Fig. 4A ).
Next, we confirmed the VE-cadherin phenotype in vitro. Consistent with previous studies (42) , confluent control shRNA transfected ECs (Casp-8 WT ECs) showed a continuous ('inhibited') VE-cadherin staining along the cell junctions ( Fig. 5A ), which became serrated with a rope-ladder pattern ('active') upon 30 or 60 min of VEGF stimulation ( Fig. 5 .B,C), as analyzed by measuring the average length of individual VE-cadherin patches (Fig.5D ). In contrast, the distribution of VE-cadherin in confluent Casp-8 KD ECs was already discontinuous/serrated in unstimulated conditions and VE-cadherin did not further rearrange upon VEGF stimulation ( Fig. 5A-D) . Moreover, VE-cadherin at the cell perimeter were reduced at basal conditions ( Fig. 5E ). However, total VE-cadherin protein levels were unchanged ( Fig.   5F ), indicating that VE-cadherin was not degraded, but only mislocalized.
Taken together, our data shows that the absence of Casp-8 in ECs affects the proper formation of adherens and tight junctions in the postnatal retina, as well as the VEGF induced remodeling of VE-Cadherin in vitro.
Loss of Casp-8 results in the basal activation of the p38 MAPK
We next pursued experiments aimed at identifying the signaling pathways involved in EC proliferation, sprouting and migration that could be altered in Casp-8 KD ECs. In the absence of Casp-8, phosphorylation of Akt, ERK and FAK was neither affected at basal conditions, nor upon VEGF stimulation (Suppl. Fig. 6A -D). However, knocking down Casp-8 or blocking its activity resulted in increased basal p38 MAPK phosphorylation ( Fig. 6A -C). Still, Casp-8 KD ECs or HUVECs treated with ZIETD were able to further activate p38 upon VEGF stimulation (Suppl. Fig. 6A , E-G). As increased activation of p38 has been linked to the destabilization of VE-cadherin in the endothelium (43, 44) , and as VE-cadherin distribution was already altered in basal conditions in Casp-8 KD ECs ( To test whether the basal increase in p-p38 in Casp-8 KD ECs was also sufficient to functionally block VEGF-induced angiogenesis in Casp-8 KD ECs, we performed the tube formation and bead sprouting assays in the presence of the p38 inhibitor. Indeed, inhibition of p38 rescued the ability of Casp-8 KD ECs to respond to VEGF and to form both tubes ( Fig. 6G and Suppl. Fig. 6H ) and sprouts ( Fig. 6H ) of a similar length as Casp-8 WT ECs.
These results indicate that the loss of Casp-8 results in destabilization of EC junctions via an increased basal phosphorylation of p38. They also indicate that the increased basal p38 activity is responsible for 11 the reduced response to VEGF, altogether resulting in overall impaired angiogenesis (see model in Fig.   7J ).
Activation of p38 MAPK upon loss of Casp-8 is mediated by RIPK3
Casp-8 inhibits RIPK3 (12) and it has recently been shown that RIPK3 regulates vessel permeability via p38 in ECs (22) . Therefore, we asked whether RIPK3 could act downstream of Casp-8 to regulate p38.
Interestingly, we observed that Casp-8 KD ECs expressed higher RIPK3 protein ( Fig. 7A ) and mRNA levels ( Fig. 7C ), as also shown in epithelial Casp-8 KO mice (46) . To investigate whether p38 was activated downstream of RIPK3 in Casp-8 KD ECs, we additionally knocked down RIPK3 and analyzed p38 phosphorylation. Knockdown of RIPK3 alone had no impact on either basal p-p38 nor on VEGFinduced p38 phosphorylation (Suppl. Fig 7A,B) . However, the basal increase in p-p38 present in Casp-8 KD ECs was rescued to control levels in Casp-8 KD /RIPK3 KD ECs (Fig. 7A,B ), indicating that RIPK3 was responsible for the increased p-p38 levels observed in Casp-8 KD cells.
Consistent with these effects on p-p38, knockdown of RIPK3 also rescued the ability of Casp-8 KD ECs to respond to VEGF and to form tube-like structures to a similar extent as seen for Casp-8 WT and RIPK3 KD ECs (Fig. 7D , Suppl. Fig. 7C ). In addition, proliferation induced by VEGF or FGF in Casp-8 KD /RIPK3 KD ECs was also partially rescued compared to Casp-8 KD ECs, as measured by BrdU incorporation (Fig. 7E ).
To confirm the role of RIPK3 in Casp-8 ECko mice in vivo, we crossed our Cdh5-(PAC)-CreERT2 x Casp-8 fl/fl mice with a RIPK3 ko mouse line (47) . In line with our in vitro results, RIPK3 did not regulate angiogenesis under physiological conditions, as neither the vessel area nor the number of branchpoints (Suppl. Fig. 7D -G) in the retina of heterozygous or homozygous RIPK3 ko pups was affected at P6 compared to wildtype littermates. In contrast, the vascular defects in Casp-8 ECko mice were rescued in Casp-8 ECko /RIPK3 ko mice as the vessel area ( Fig. 7F -H) and number of branchpoints ( Fig. 7I ) were similar to Casp-8 WT /RIPK3 ko mice.
In summary, these results show that in the absence of Casp-8, RIPK3 is mediating increased phosphorylation of p38 in vitro and impaired developmental vascular growth in vivo. Together, we propose that this RIPK3/p-p38 axis deregulates EC behavior resulting in impaired angiogenesis ( Fig.   7J ). Despite the better control of oxygen administration to preterm infants, ROP persists in extremely low gestational ages and birthweights and is still a clinical problem (48) . ROP is characterized by two phases. In phase 1, exposure of preterm infants to high extra-uterine oxygen levels causes cessation of vessel growth. However, as the metabolic demand of the retina increases over time and as there is a lack of proper tissue oxygenation, upregulation of VEGF induces pathological neovascularization, consisting of extensive extra-retinal neovascular tufts in phase 2 of ROP (49) . As our in vitro data showed that Casp-8 KD ECs were not able to respond to VEGF, we explored whether the loss of Casp-8 could also reduce pathological angiogenesis during ROP. We therefore applied the oxygen-induced retinopathy (OIR) model, which resembles very well the two phases of ROP (50, 51) . In this model, high oxygen levels induce rapid vessel regression followed by upregulation of VEGF that causes pathological vessel sprouting and formation of abnormal and leaky vascular tufts. 13 For this, we exposed pups to high oxygen levels (75%) to induce vessel regression from P7 to P10 ( Fig.   8A ), as previously described (35) . Subsequently, pups were returned to normoxia until P15, causing the now avascular retina to become hypoxic and upregulate VEGF, inducing the neovascular response. Cre recombination and Casp-8 deletion was induced on return to normoxia from P10 to P14 to evaluate the effect of Casp-8 loss on pathological neovascularization (Fig. 8A ). Analysis of the retinal vasculature at P15 showed that pathological neovascularization (quantified by measuring the neovascular tuft area (52)) was strongly reduced in Casp-8 ECko compared to Casp-8 WT retinas (Fig. 8C, D) , supporting the concept that blocking Casp-8 is beneficial to prevent disease progression. In addition to pathological neovascularization, normal angiogenesis gradually replaces the vessels lost from the central retina following exposure to high oxygen. Analysis of the avascular area showed a slight increase in Casp-8 ECko pups compared to wildtype littermates ( Fig. 8B, E ). This result is probably a combination of reduced pathological neovascularization and a reduced vessel regrowth, consistent with our finding that angiogenesis and the response to VEGF were reduced in Casp-8 KD ECs.
Casp-8 ECko mice show reduced pathological angiogenesis in a model
Finally, to examine vessel integrity and functionality of the newly formed vasculature, we analyzed vessel perfusion by retro-orbital injection of IsolectinB4-A647 (which attaches to the vessel lumen and hence, labels perfused vessels), as previously described (53, 54) . Then, the isolated retinas were costained with IsoB4-A568 to determine the vessel area. Analysis of IsolectinB4-Alexa647 per vessel area revealed efficient vessel perfusion in both genotypes ( Figure 8F ,H).
Taken together, targeting Casp-8 in ECs in a model of OIR, resembling ROP, could indeed be beneficial as it reduces the severity of tuft formation without compromising the newly formed vasculature. 14 
DISCUSSION
Components of both the intrinsic and extrinsic apoptosis signaling pathways have been described to be active in ECs and involved in different processes during the formation of the vascular system. While the intrinsic pathway of apoptosis (induced by the activation of Bax and Bak) is crucial for the regression and cell death of ECs from hyaloid vessels in the retina (55) (56) (57) (58) , this pathway controls EC number (8, 10, 59-61), but is not an active driver of vessel remodeling/pruning in the postnatal retina vasculature.
On the other hand, activation of the extrinsic signaling machinery via activation of CD95 expressed in retinal ECs contributes to vessel development by regulating EC proliferation instead of cell death (62) .
Casp-8 is a key protease in the extrinsic cell death signaling pathway that has both cell death-inducing and pro-survival functions (21) . A basal Casp-8 activity is required for cell survival as it inhibits the activation of RIPK3 and thus the subsequent phosphorylation of MLKL leading to necroptosis (63) . In pathological conditions, tumor-induced EC necroptosis has been described as a mechanism via which tumor cells extravasate and metastasize (23) . However, in the same tumor model it has also been shown that RIPK3 regulates vessel permeability independent of EC necroptosis (22) . Here we show that necroptosis is not involved in postnatal developmental angiogenesis, as the vascular defects in Casp-8 ECko mice are still present in Casp-8 ECko /MLKL ko retinas. Notably, proper angiogenesis was restored in Casp-8 ECko /RIPK3 ko pups, indicating that the vascular impairments in Casp-8 ECko mice were mediated by RIPK3, thus assigning a necroptosis-independent function for RIPK3 in ECs during angiogenesis.
Cell death-independent functions of Casp-8 have been shown to be both activity dependent (16, 64) and independent (acting as a scaffold protein (14, 32) ). While we do not rule out that Casp-8 could also act as a scaffold protein to regulate the angiogenic response of ECs, here we show that its activity is required. The cellular substrate for Casp-8 in ECs during angiogenesis has yet to be identified. However, as RIPK3 mRNA levels are upregulated in Casp-8 KD ECs, similar as in epithelial cells without Casp-8 (46) , transcriptional regulators might be involved. 15 Mechanistically, Casp-8 deletion in ECs results in EC proliferation, sprouting and VE-cadherin subcellular distribution defects. Analysis of different signaling pathways revealed that Casp-8 KD ECs had increased basal activation of p38. Consistent with our findings, loss of Casp-8 in the epidermis has also been shown to induce the upregulation of p-p38 (65) . Despite the fact that VEGF stimulation activated ERK, Akt, FAK and p38 in Casp-8 KD ECs, this did not result in a functional angiogenic response in vitro.
However, when p38 activity was blocked, Casp-8 KD ECs responded normally to VEGF stimulation in the sprouting and tube formation assay. These findings indicate that the basal overactivation of p38 was already enough to functionally inhibit the response of Casp-8 KD ECs to VEGF and thus to impair angiogenesis. It was previously reported that p38 activity induces EC migration (66) . However, in our experimental set-up, EC migration was not affected in Casp-8 KD ECs under basal conditions, even though p38 was already higher activated. As migration of Casp-8 KD ECs does not change in basal conditions, this suggests that p38-independent mechanisms might account for this phenotype. We could also link RIPK3 to p38 hyperactivation, as in vitro knockdown of RIPK3 in Casp-8 KD ECs rescued the basal phosphorylation of p38 to control levels. Further studies are needed to investigate how RIPK3 is regulating p38, and whether RIPK3 activity is required.
Specific loss of Casp-8 in the epidermis results in increased p38 phosphorylation (65) and loss of junction integrity in epithelial cells, independent of cell death (40) . Here we show that loss of Casp-8 in ECs in vitro resulted in impaired distribution of VE-cadherin at the cell membrane, creating a serrated pattern. Moreover, Casp-8 KD ECs failed to induce VE-cadherin rearrangements required for proper angiogenesis upon VEGF stimulation. This phenotype was rescued when p38 was inhibited in vitro. So far, it is not very well understood how p38 regulates VE-Cadherin localization in physiological conditions. However, tumor transendothelial cell migration studies suggest that p38 does not act directly on VE-Cadherin, but rather promotes its internalization via the formation of stress fibers (67) . We therefore hypothesize that the activation of p38 in the absence of Casp-8 could cause the VE-Cadherin defects via a similar mechanism.
In vivo, VE-cadherin stability was altered at the back of the retina of Casp-8 ECko EC pups, suggesting that EC-EC contacts fail to stabilize. Recent studies indicate that rather than its sole presence or 16 absence (35) (36) (37) 39) , it is the dynamic and heterogeneous expression of VE-cadherin in different areas of the developing vessel sprout that drives angiogenesis (38) . Consistent with this current view, which suggests that EC junctions in the back of the retina have to be stabilized in order to allow proper sprout elongation in the front, we postulate that the increased number of vessel patches with serrated junctions in the back of Casp-8 ECko retinas blocks EC positional interchanges, ultimately resulting in a reduced number of sprouts at the vascular front and thus reduced angiogenesis.
In many pathological conditions such as ROP, proliferative diabetic retinopathy (PDR) and retina vein occlusion (RVO), among others, pathological retina neovascularization following tissue hypoxia is characterized by excessive extra-retinal neovascular tufts (50, 68) . In fact, it is the aberrant neovascularization in these patients that causes the biggest clinical challenge (blindness), rather than vessel regression itself (68) . Here, by applying a model of oxygen-induced retinopathy (OIR), resembling ROP and producing neovascular lesions resembling those of PDR or RVO, we describe that Casp-8 is mechanistically involved in the pathophysiology of ocular neovascular diseases, Indeed, Casp-8 ECko mice, were Casp-8 was deleted in ECs just during the neovascularization phase, presented reduced aberrant vascular tufts. Consistent with our findings that Casp-8 KD ECs have a reduced response to VEGF stimulation and thus show reduced VEGF-induced angiogenesis, we also observed a slight increase in the avascular area, suggesting that the newly regrowing vessels develop slower in Casp-8 ECko retinas compared to Casp-8 WT ones (however, we cannot exclude that in this specific setting, necroptosis contributes to the increased avascular area observed in Casp-8 ECko mice). Nevertheless, based on the fact that in physiological conditions Casp-8 ECko retinas finally achieve a normal and functional vasculature, we propose that inactivation of Casp-8 in an ischemic retinopathy pathological setting, such as ROP, is beneficial as it will inhibit aberrant neovascularization, and, in a similar way as in development, the avascular area will be finally recovered.
EXPERIMENTAL PROCEDURES
Mouse lines and treatment
Casp-8 fl/fl mice (69) were crossed with Cdh5(PAC)-CreERT2 mice (24) , to specifically delete Casp-8 in the the endothelium upon tamoxifen treatment. MLKL ko mice were provided by M. Pasparakis (CECAD, Cologne). RIPK3 ko mice (47) were provided by Genentech (South San Francisco, CA, USA). Pregnant females were intraperitoneally injected with 2mg tamoxifen/30g body weight from E8.5 until E10.5.
Embryos were dissected at E13.5 and assessed for heart beat (alive), death or presence of malformations such as bleedings or (cardiac) edema (Suppl. Fig. 1B ). Recombination in pups was induced by intragastric injection of 50µl tamoxifen (1mg/ml) at postnatal day (P)1-P3 and P5 as described in Figure 1A . For analysis at P15 and P42, pups received additional tamoxifen injections (i.p.) at P8, P11 and P14.
Oxygen induced retinopathy model
To induce retinal pathological angiogenesis in Casp-8 ECko mice, the OIR model was used as previously described (35) . From P7 to P10, pups were placed in 75% oxygen (hyperoxia); at P10 pups were returned to normal oxygen conditions (normoxia) until P15 (35) . Cre recombination was induced by i.p. injection of 50µl tamoxifen (2mg/ml) at P10 -P12 and P14. To analyze vessel perfusion, pups at P15 were retro-orbitally injected with IsoB4-Alexa 647 (5mg/kg body weight) as previously described (54) and sacrificed after 5 min. Retinas were isolated and fixed in 4%PFA/PBS for 1h at room temperature (RT). Conditions used for the retina staining are specified in the "Retina staining" section. Quantification of the size of the avascular area and neovascular tufts was performed in Adobe Photoshop blind to experimental conditions as previously described (52) . To quantify vessel perfusion, mean fluorescent intensity of injected IsoB4-Alexa 647 was normalized to the intensity of IsoB4-Alexa 568 stained vasculature as previously described (54) .
Analysis of EC proliferation in vivo
EdU (Thermo Scientific) was injected at a concentration of 100 µg/g body weight into P6 Casp-8 ECko pups as previously described (70) 2.5 h before culling. Eyes were fixed in 4%PFA for 1.5h at 4°C. EdU + cells in the retina were detected with the Click-iT™ EdU Alexa Fluor™ 488 Imaging Kit (Thermo Scientific) according to manufacturer's instructions. ECs were counterstained with ERG and IsoB4.
Eight pictures/pup of the angiogenic front were imaged at 20x magnification with a LSM 510 META.
Quantification was done blind to experimental conditions. The number of proliferating ECs is expressed as EdU + /ERG + cells normalized to the IsoB4 + vessel area per field of view.
Whole mount staining of the yolk sac vasculature
Yolk sacs were fixed overnight in 4% PFA/PBS at 4 °C. After permeabilization in 1% Triton X-100/PBS for 1h at RT and blocking in 0.2% BSA, 5% normal donkey serum (Dianova), 0.3% TritonX-100 in PBS for 2h at RT, primary antibody Endoglin (1:200, MAB1320, R&D Systems) was incubated overnight at 4 °C in blocking solution. The appropriate Alexa Fluor TM -conjugated secondary antibody was incubated overnight at 4°C. Whole mount images were acquired on a LSM 510 META confocal microscope.
Retina dissection, processing and staining
Eyes were collected and enucleated in PBS. For VE-Cadherin stainings, eyes were fixed in 2% PFA/PBS for 1h at 4ºC. For all other stainings, eyes were fixed for 1.5h in 4% PFA/PBS at 4ºC. Retinas were dissected, permeabilized with PBS containing 1% BSA, 0.3% Triton X-100 for 1h and incubated with primary antibodies at 4°C overnight. Antibodies used were Alexa Fluor TM 594-conjugated was done in 0.5% Triton X-100/0.1% citrate in PBS for 3h at RT. Then, labelling of TUNEL + cells was done for 1h at 37 °C. After washing, samples were stained with FITC-conjugated IsoB4 (1:250, ALX-650-001F-MC05, Enzo Life Sciences) in 1% BSA, 0.3% Triton X-100/PBS for 1h at RT. Retinas were flat-mounted and analyzed using a confocal fluorescence microscope (LSM 510 META or LSM800; Carl Zeiss).
Analysis of VE-cadherin localization in ECs in vivo
For analysis of VE-Cadherin in the retina of P6 pups, high magnification pictures (63x) were acquired.
Two pictures from either the angiogenic front or the back of the retina were randomly taken in areas adjacent either to a vein or an artery. Representative inset pictures show the most active or inhibited pattern of VE-cadherin in Casp-8 WT and Casp-8 ECko pups. Quantification of the percentage of VEcadherin patches was done blind to experimental conditions in MATLAB as previously described (35) .
In situ hybridization in the retina
In situ hybridization (ISH) was performed with minor modifications as previously described (71) . In brief, eyes of P6 pups were removed and fixed for 20 min in 4% PFA on ice. After isolation and dissection, retinas were stored in methanol at -20°C overnight. Hybridization was performed at 66°C. Primer sequences to generate probes to detect mouse Casp-8 are: Casp-8-Fwd 3'-TTTCCACATCAGTCGGTGGG-5' and Casp-8-Rev 3'-CTCTTGGCGAGTCACACAGT-5'. After color development, retinas were extensively washed with PBS and counterstained with Alexa Fluor TM 594conjugated IsoB4. Bright field and fluorescent images were acquired simultaneously using a Zeiss LSM 800 (20x objective). Bright field images were processed and background corrected with a rolling ball algorithm in NIH ImageJ.
Lung endothelial cell isolation
Murine lung ECs were isolated by MACS ® Technology (Miltenyi Biotec). Lungs of P6 mouse pups were isolated and kept in ice-cold HBSS containing 10% FCS. Tissue from Casp-8 WT and Casp-8 ECko pups 20 from the same litter were pooled and digested in collagenase I/DNAse I (0.1mg/ml, Roche) at 37°C. The digested tissue was filtered, incubated with Red Blood Cell Lysis Buffer (Roche) and washed several times with PEB buffer (0,5% BSA, 2 mM EDTA in PBS). Negative selection of CD45 + cells was performed by incubation of the cell suspension with CD45 MicroBeads (1:10) for 15min at 4°C. Cell suspensions were applied onto LS columns and unlabeled cells were collected on ice. Enrichment of ECs was performed using CD31 MicroBeads (1:10) in PEB buffer for 15 min at 4°C and application on MS columns. The positive cell fraction was eluted from the columns with PEB buffer and directly frozen in RLT buffer (Qiagen) for RNA isolation.
Cell culture
Human umbilical vein endothelial cells (HUVECs; PromoCell) were cultured in Endopan 3 Kit for endothelial cells (PAN-Biotech) supplemented with 10% FBS, 100 U/ml penicillin and 100 µg/ml streptomycin (both Gibco ® by Life Technologies) in a 5% CO2 humidified incubator at 37ºC. Cells from passages 2 to 5 were used for the experiments. When indicated, cells were starved in growth factorfree Endopan 3 supplemented with 2% FBS, 100 U/ml penicillin and 100 µg/ml streptomycin.
RNA extraction and quantitative Real-Time PCR analysis
RNA was extracted with the mini RNA extraction kit (Qiagen). RNA samples were transcribed to complementary DNA using Maxima Reverse Transcriptase (Thermo Scientific) or SuperScript VILO cDNA Synthesis Kit (Invitrogen). qRT-PCR was performed using Fast SYBR Green Master Mix (Thermo Scientific). Either GAPDH or ActB were used as housekeeping genes. All qPCR results from cultured cells were obtained from at least 3 independent experiments. Results from lung isolated ECs are from 4 independent litters.
siRNA transfection
HUVECs were seeded in a 6 well plate (9x10 4 -11x10 4 cells/well). The next day, cells were transfected with MISSION® siRNA Universal Negative Control (Sigma-Aldrich) or previously validated siRNAs for 21 Casp-8 (72) and/or RIPK3 (22) using Oligofectamin (Life Technologies), according to the manufacturer's instructions. The final concentration of siRNA solution was 200nM.
Lentiviral vectors and virus production
For silencing experiments, previously used and validated lentiviral vectors to express shRNAs against Caspase-8, c-FLIP or control (29, 73, 74) were used. Lentiviruses were produced by transfection of HEK293-T cells with the calcium phosphate method with the corresponding vectors. Lentiviruscontaining supernatants were collected 48/72 h after transfection and concentrated by ultracentrifugation at 22,000 rpm for 90 minutes at 4 ºC.
Analysis of VE-cadherin localization in ECs in vitro
For VE-cadherin staining in HUVECs, 1x10 5 
In vitro BrdU incorporation
To analyze EC proliferation in vitro, 25x10 3 infected HUVECs (shCtrl or shCasp-8) were plated in 0.1% gelatin/water coated coverslips. After overnight starvation, cells were treated with or without VEGF 22 (50ngml) or FGF (50n/ml), for 24 h. BrdU (10μM) was added and incubation of the cultures continued for 4h at 37°C. Cells were fixed in 4% PFA/PBS for 20min and permeabilized and blocked in 2% BSA 0.3% Triton X-100/PBS for 30min at RT. After unmasking with ice-cold HCl, neutralization with sodium borate buffer (0.1M Na2B4O7 in water, pH 8.5) for 15min was done prior to primary antibody incubation. 
WST-1 assay
The WST-1 cell proliferation and viability assay (Sigma-Aldrich) was done according to the manual as previously described (33) . Briefly, transfected HUVECs were plated in a 96 well plate and allowed to attach overnight. Then, cells were starved overnight and stimulated with VEGF (50ng/ml) or control vehicle for 24h.
Fibrin gel bead sprouting assay
Fibrin gel bead sprouting assay was performed as previously described (75) . Briefly, cytodex 3 microcarrier beads (GE Healthcare) were coated with siRNA-transfected or shRNA-infected HUVECs (mixed at 200 cells per bead), and embedded in 2 mg/mL fibrin gels ( 2 mg/mL fibrinogen (Calbiochem), 0.625 Units/mL thrombin (Sigma-Aldrich) and 0.15 Units/mL aprotinin (Sigma-Aldrich)). Beads were cultured in 2% FBS growth factor-free Endopan 3 medium, in presence or absence of 50ng/ml VEGF.
After 24 hours the culture was fixed with 4% PFA for 15min, blocked in 1% BSA, 0.2% TritonX-100-PBS and incubated with 1µg/mL Phalloidin-fluo (94507, Sigma-Aldrich) for 2h. Confocal images were taken with a Zeiss LSM 510 microscope and analyzed by NIH ImageJ. Quantification was done blind to 23 experimental conditions. Approximately 20 beads per condition were quantified from 4 independent experiments.
Single endothelial cell tracings
Single EC tracings were performed as previously described (33) . Infected ECs with shRNA control or shCasp-8 were plated on 6 well plates and stimulated with 50ng/ml VEGF or control vehicle (after 
Tube formation
Tube formation assays were performed in μ-Slide Angiogenesis wells (ibidi GmbH, Germany) as previously described (33, 76) using 10 μl of growth factor-reduced Matrigel (BD Bioscience) per well. In brief, siRNA transfected or lentivirus infected HUVECs resuspended in 2% FBS growth factor-free Endopan 3 medium, with or without VEGF (50ng/ml), were seeded onto the polymerized matrigel.
Wherever indicated, prior to seeding on Matrigel, cells were pre-treated overnight with SB203580 (1µM).
Cells were incubated for 4h in a humidified chamber at 37°C, 5% CO2 before analysis. Images were acquired with a wide field microscope (Zeiss Axiovert 200) equipped with an Axiocam MRm camera and a 5x objective. At least 3 fields of view per condition were acquired. Quantification of three independent experiments was done blind to experimental conditions with the Angiogenesis analyzer tool of NIH ImageJ.
Scratch assay
siRNA transfected HUVECs were seeded in a 6 well plate. When cells were confluent, they were starved in 2%FBS growth factor-free Endopan 3 medium overnight. A wound was induced by scraping the cell 24 monolayer with a P200 pipet tip and cells were stimulated with or without VEGF (50ng/ml). A picture was acquired at time-point zero and 12h after incubation at 37°C.The percentage of wound closure between 0h and 12h of VEGF stimulation was analyzed with NIH ImageJ, blind to experimental conditions. Results are from at least 3 independent experiments. For each treatment 8-10 fields of view were analyzed.
In vitro cell death assay
Infected HUVECs (1x10 5 cells/well in 6 well plates) were treated with TNF-α (100ng/ml, Preprotech) and TRAIL (100ng/ml, homemade) in normoxia or hypoxia (0,1% O2, BioSpherix, X2, Exvivo System) during 24h. After treatment, cells were washed with PBS, and stained with PI (40ug/ml) while treating with RNase (100ug/ml). Quantitative analysis of PI + cells was carried out in a FACSCalibur cytometer using the Cell Quest software (Becton Dickinson).
Caspase-8 Glo assay
The Caspase-8 Glo® assay was performed in combination with the CellTiter-Fluor™ Cell Viability Assay 
Statistics
Results are expressed as mean ± SEM. To calculate statistical significance, the two tailed Student's ttest, one sample t-test, one-way ANOVA or two-way ANOVA followed by Bonferroni's multiple comparisons test were used and indicated in the appropriate figure legend. To calculate statistical significance in Fig. 4 (analysis of VE-Cadherin distribution in vivo), Dirichlet regression model was applied for the analysis of binned data. Additional Mann-Whitney tests for each state are reported to indicate states with strong differences between groups. All calculations were performed using Prism software.
Study approval
All animal procedures were conducted in accordance with European, national, and institutional guidelines. Protocols were approved by local government authorities (Regierungspräsidium Karlsruhe, Germany). one sample t-test; for E-H * P <0.05, ** P <0.01, *** P <0.001, ns: not significant; two-way ANOVA with Bonferroni's multiple comparisons test). Scale bars: D) 20µm. 
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